TRENDING :  Market Movers  |  Top 50   UGAZ (-5.55%)    MU (-1.97%)    AMD (0.75%)    DGAZ (5.51%)    SPY (1.15%)    TSLA (3%)    VXX (-4.57%)    NBEV (1.15%)    VXXB (-4.35%)    UXIN (8.49%)    TWLO (2.76%)    TLT (-0.37%)    SQQQ (-5.84%)    SPX (1.15%)    PRQR (4.72%)    PDD (0.17%)    NFLX (6.52%)    MNGA (4.65%)    MBOT (-7.26%)    INTC (0.52%)    HUYA (2.48%)    HCLP (0%)    CGC (-2.81%)    AFMD (2.06%)

 GLMD - Galmed Pharmaceuticals Ltd.

$8.56 (1.07%)

Next Earnings

3/12/2019

BMO


Analyst Rating

CompanyAnalyst NamePT ActionActionRatingTargetDate
B. Riley FBRAnnouncesInitiates Coverage OnBuy$28.0012/12/18

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $GLMD

Service NameTrader% Success
ScalpingRenHen Investments84.00 %Follow
Biotech picksmr jackson50.00 %Follow
British Bull TraderJohn Drummond27.00 %Follow

TRENDING ARTICLES


Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018

12/28/18
Shares of Intercept Pharmaceuticals Inc ICPT have gained 59 2 in the year so far against the industry s decline of 25 6 Intercept s focus is on treating orphan and more prevalent liver diseases with limited treatment options The company received a significant boost with